TL;DR:
- NEJM Group introduces NEJM AI, a peer-reviewed journal focused on AI and machine learning in medicine.
- NEJM AI provides original research, reviews, and educational content for healthcare professionals.
- The journal offers benchmark data sets for testing and advancing medical AI knowledge.
- AI applications in medicine have been slow to adopt, but NEJM AI aims to bridge the gap.
- The market for AI in healthcare is projected to grow from $11 billion in 2021 to $188 billion by 2030.
- NEJM AI maintains rigorous standards for evaluating AI tools in clinical settings.
- The journal promotes dialogue and ethical considerations regarding AI’s role in healthcare.
Main AI News:
In a dynamic stride towards innovation and transformation in the healthcare sector, the NEJM Group, the illustrious publisher of the New England Journal of Medicine, proudly presents its latest venture, NEJM AI. This groundbreaking, peer-reviewed monthly journal stands as a beacon of knowledge and exploration at the intersection of medicine, artificial intelligence (AI) and machine learning.
NEJM AI, much like its esteemed predecessor, brings forth a wealth of original research articles, comprehensive reviews, astute policy perspectives, and educational resources tailored for a diverse audience encompassing clinicians, scientists, healthcare leaders, policymakers, regulators, and executives hailing from the pharmaceutical, device-manufacturing, and technology industries. Beyond its conventional offerings, NEJM AI distinguishes itself with a distinctive feature – benchmark data sets and protocols, readily available to practitioners, fostering the testing and advancement of medical AI knowledge.
Eric Rubin, M.D., Ph.D., the luminary editor-in-chief of the New England Journal of Medicine and NEJM Group publications, underscores the journal’s mission, stating, “What many people don’t know is that AI is already being used in medicine. Our newest peer-reviewed journal, NEJM AI, will traverse this rapidly evolving landscape to provide clinicians with trusted, high-quality evidence and educational material, ultimately aiming to enhance healthcare for patients worldwide.”
Over the past decade, the Food and Drug Administration has granted approval to AI-powered devices capable of interpreting medical images and aiding clinicians in diagnostic decision-making. Yet, despite meeting regulatory standards, the medical community has been cautiously receptive to the potential of AI applications in healthcare. NEJM AI aspires to serve as an indispensable resource for medical professionals seeking an in-depth comprehension of how groundbreaking AI and machine learning applications will be evaluated, subsequently influencing clinical practice.
Isaac (Zak) Kohane, M.D., Ph.D., the editor-in-chief of NEJM AI, expounds, “We stand at the precipice of a transformative era in medicine, with AI poised to become an integral participant in medical decision-making. AI is not a transient trend; it will revolutionize the practice of medicine and reshape the doctor-patient relationship. NEJM AI will apply the same unwavering standards as our flagship journal to ascertain which AI tools are primed for integration into medical settings.” For further insights from Dr. Kohane and the editorial team, readers can delve into the editorials authored by Kohane and Koller.
According to Statista, the global AI healthcare market in 2021 surged to $11 billion (USD), a figure anticipated to ascend to a staggering $188 billion by 2030. As Charlotte Haug, M.D., Ph.D., Executive Editor of NEJM AI, asserts, “With such exponential growth, it becomes imperative that AI tools adhere to the same rigorous standards of medical evidence expected from traditional clinical interventions. Our editorial team, comprising clinical and biomedical informatics experts, is committed to publishing pivotal trials designed to evaluate AI tools against established benchmarks, thereby upholding stringent safety criteria.”
In a bid to foster a sense of community and facilitate dialogue, NEJM AI offers the NEJM AI Grand Rounds podcast, hosted by deputy editors Arjun (Raj) Manrai, Ph.D., and Andrew Beam, Ph.D. This engaging podcast features candid conversations with leading experts, delving into the intricate nexus of artificial intelligence, machine learning, and medicine. Moreover, the journal organizes virtual events that provide a platform for open discussions surrounding the value, ethics, and quality of medical AI.
NEJM AI is poised to deliver an array of perspectives on the paramount ethical and legal challenges and risks associated with the development and deployment of AI in clinical settings. The journal’s mission is clear: to ignite stimulating dialogues among clinicians utilizing medical AI, the tech visionaries shaping the technology, and the patients who reap the benefits of these transformative applications. NEJM AI stands as a vanguard in the dynamic realm where medicine converges with artificial intelligence, illuminating the path toward a brighter future in healthcare.
Conclusion:
The launch of NEJM AI signifies a pivotal moment in the healthcare market. As AI becomes increasingly integral to medical decision-making, this journal provides a trusted resource for professionals. The projected growth in the AI healthcare market to $188 billion by 2030 highlights the importance of rigorous standards, and NEJM AI’s commitment to ethical discussions will shape the responsible development and deployment of AI in clinical settings, ensuring a transformative impact on healthcare.
